Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma

References

• Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38: 352–7.
   PubMed Web of Science ®Google Scholar
• Alvarez RD, Soong SJ, Kinney WK, Reid GC, Schray MF, Podratz KC et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 1989; 35: 130–5.
   PubMedGoogle Scholar
• Sardi JE, di Paola GR, Cachau A, Ortiz OC, Sananes C, Giaroli A et al. A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol 1986; 25: 139–49.
   PubMed Web of Science ®Google Scholar
• Sardi JE, di Paola GR, Giaroli A, Sananes C, Gomez Rueda N, Cachau A et al. Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri. Gynecol Oncol 1988; 31: 256–61.
   PubMedGoogle Scholar
• Greco P, Cormio G, Vimercati A, Nacci G, di Vagno G, Loverro G et al. Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer. Acta Obstet Gynecol Scand 1997; 76: 169–72.
   PubMed Web of Science ®Google Scholar
• Manfredi R, Maresca G, Smaniotto D, Greggi S, Andrulli D, Rabitti C et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology 1988; 209: 819–24.
   Google Scholar
• Folkman J. Angiogenesis: initiation and control. Ann N Y Acad Sci 1982; 401: 212–27.
   Google Scholar
• Wu CC, Lee CN, Chen TM, Shyu MK, Hsieh CY, Chen HY et al. Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 1994; 73: 1251–6.
   Google Scholar
• Cheng WF, Chen CA, Lee CN, Chen TM, Huang KT, Hsieh CY et al. Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients. Gynecol Oncol 1998; 71: 424–7.
   Google Scholar
• Cheng WF, Chen TM, Chen CA, Wu CC, Huang KT, Hsieh CY et al. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma. Cancer 1998; 82: 1881–6.
   Google Scholar
• Cheng WF, Lee CN, Chu JS, Chen CA, Chen TM, Shau WY et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 1999; 85: 651–7.
   PubMed Web of Science ®Google Scholar
• Cheng WF, Wei LH, Su YN, Cheng SP, Chu JS, Lee CN. The possible use of colour flow Doppler in planning treatment in early invasive carcinoma of the cervix. Br J Obstet Gynaecol 1999; 106: 1137–42.
   PubMedGoogle Scholar
• Wu CH, Hsu MM, Chang YL, Hsieh FJ. Vascular pathology of malignant cervical lymphadenopathy: qualitative and quantitative assessment with power Doppler ultrasound. Cancer 1998; 83: 1189–96.
   Google Scholar
• Wu CH, Chang YL, Hsu WC, Ko JY, Sheen TS, Hsieh FJ. Usefulness of Doppler spectral analysis and power Doppler sonography in the differentiation of cervical lymphadenopathies. Am J Roentgenol 1998; 171: 503–9.
   PubMed Web of Science ®Google Scholar
• Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A et al. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 1998; 178: 314–19.
   PubMed Web of Science ®Google Scholar
• Cheng WF, Lee CN, Chen CA, Chu JS, Kung CCS, Hsieh CY et al. Comparison of ‘‘in vivo’’ and ‘‘in vitro’’ methods for evaluating angiogenesis and their clinical application in cervical carcinoma. Angiogenesis 1999; 3: 63–6.
   Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8.
   PubMed Web of Science ®Google Scholar
• Dimitrakopoulou-Strauss A, Strauss LG, Rudi J. PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Q J Nucl Med 2003; 47: 8–13.
   Google Scholar
• Padhani AR. Functional MRI for anticancer therapy assessment. Eur J Cancer 2002; 38: 2116–27.
   PubMed Web of Science ®Google Scholar
• Campiglio M, Somenzi G, Olgiati C, Beretta G, Balsari A, Zaffaroni N et al. Role of proliferation in HER2 status predicted response to doxorubicin. Int J Cancer 2003; 105: 568–73.
   PubMed Web of Science ®Google Scholar
• Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis L, Boven E et al. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol Cancer Ther 2002; 1: 371–6.
   Google Scholar
• Penault-Llorca F, Cayre A, Bouchet Mishellany F, Amat S, Feillel V, Le Bouedec G et al. Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome. Int J Oncol 2003; 22: 1319–25.
   Google Scholar
• Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R et al. P53 is the strongest predictor of survival in highrisk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support. Int J Cancer 2002; 100: 290–6.
   Google Scholar
• Gadducci A, Viacava P, Cosio S, Fanelli G, Fanucchi A, Cecchetti D et al. Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma. Anticancer Res 2003; 23: 549–56.
   PubMed Web of Science ®Google Scholar
• Bottini A, Berruti A, Bersiga A, Brizzi MP, Allevi G, Bolsi G et al. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. Clin Cancer Res 2002; 8: 1816–21.
   PubMedGoogle Scholar
• Shimada H, Hoshino T, Okazumi S, Matsubara H, Funami Y, Nabeya Y et al. Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. Br J Cancer 2002; 86: 552–7.
   PubMed Web of Science ®Google Scholar
• Orden MR, Jurvelin JS, Kirkinen PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 2003; 226: 405–10.
   Google Scholar
• Alcazar JL, Jurado M. Transvaginal color Doppler for predicting pathological response to preoperative chemoradiation in locally advanced cervical carcinoma: a preliminary study. Ultrasound Med Biol 1999; 25: 1041–5.
   PubMed Web of Science ®Google Scholar
• Suren A, Osmers R, Kuhn W. 3D color power angioimaging: a new method to assess intracervical vascularization in benign and pathological conditions. Ultrasound Obstet Gynecol 1998; 11: 133–7.
   Google Scholar
• Amano M, Kato T, Amano Y, Kumazaki T. Using MR imaging to predict and evaluate the response of invasive cervical carcinoma to systemic chemotherapy. Am J Roentgenol 1998; 171: 1335–9.
   Google Scholar
• Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Brix G, Zuna I et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 1998; 58: 3598–602.
   PubMed Web of Science ®Google Scholar
• Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P et al. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. Cancer Res 1999; 59: 5602–7.
   Google Scholar
• Matsuura T, Kuratate I, Teramachi K, Osaki M, Fukuda Y, Ito H. Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas. Cancer Res 1999; 59: 5037–40.
   PubMed Web of Science ®Google Scholar